Phase I trial of NT 113 for the treatment of cancer.
Phase of Trial: Phase I
Latest Information Update: 15 Dec 2014
At a glance
- Drugs NT 113 (Primary)
- Indications Cancer; Glioblastoma; Head and neck cancer; Non-small cell lung cancer
- Focus Therapeutic Use
- 04 Apr 2013 New trial record